CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.

Fuelled by precision medicine and rising global incidence, the sector combines North American revenue dominance with Asia’s expanding recruitment capacity. As advanced modalities mature, stakeholders ...

These drugs have become easier to take and cheaper to produce ...

Novo Nordisk A/S (NOVO:CA) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 12:45 PM ESTCompany ...

Positioned to increase depth of Vafseo prescribing entering 2026 with access to approximately 275,000 patients First patient dosed in ...

Select Medical Holdings Corporation ("Select Medical") , will release the financial results for its fourth quarter and full year ended December 31, 2025 on Thursday, February 19, 2026 after the market ...

The global cyanocobalamin market size was US$ 167.7 billion in 2021. The global cyanocobalamin market is forecast to grow to US$ 250.1 billion by 2030, registering a compound annual growth rate (CAGR) ...

WAKIX 2025 Preliminary Net Revenue of ~$868 Million; 2026 WAKIX Net Revenue Guidance of $1.0 – $1.04 Billion on Track for Blockbuster Status in NarcolepsyOn Track to Extend the Pitolisant Franchise ...

In the wake of last week's release of a 2026-2030 USDA Dietary Guidelines for Americans (DGA) devoid of any concrete advice ...

Amid economic and geopolitical uncertainties, we look at the promise and perils for different sectors—from banking and artificial intelligence to pharma and automobiles—this year ...